Octave Bioscience
Octave Bioscience is a precision neurology company founded in 2014 and headquartered in Menlo Park, California, that develops blood-based multi-protein biomarker tests for chronic neurological disease. Its commercially available Octave Multiple Sclerosis Disease Activity (MSDA) Test measures a panel of serum proteins to produce a quantitative disease activity score used alongside clinical and imaging assessment, and is available across the United States through a strategic collaboration with Quest Diagnostics. The company is also developing a Multiple Sclerosis Disease Progression (MSDP) test and a Parkinson's disease biomarker assay supported by a Michael J. Fox Foundation grant. Octave publishes a public trust center documenting HITRUST, ISO/IEC 27001:2022, ISO/IEC 42001:2023, HIPAA and GDPR posture, but operates no public developer program, API reference, SDK or machine-readable specification.
Octave Bioscience is profiled on the APIs.io network. Tagged areas include Company, Health Care, Life Sciences, Diagnostics, and Neurology.
Octave Bioscience’s developer surface includes support, product news, and 11 more developer resources.
Kin Score
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 3
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Other 2
Properties that don't map to a standard resource type